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According to Friedman ( 1 ) , the nature of the X substituent (usually halogen, theophylline or thioglycolate) has no effect on diuretic potency if the compound is given intravenously, but does influence both hyperacute (cardiac and respiratory arrest) and acute (7 to 14-day) renal toxicity. The nature of the OY group is determined by the solvent in which the mercuration is carried out and is an hydroxyl group, if the solvent is water. or a methoxy or ethoxy group, if the solvent is the corresponding alcohol. Within these limits, i.e., OH, OCH3, or OC.,H5, the nature of the OY group is without appreciable effect on either diuretic potency or toxicity. In contrast, the nature of the R group, which is commonly rather complex, has a very great effect on both toxicity and diuretic activity. In the diuretic mersalyl, R is o-carbamylphenoxyacetic acid; in mercaptomerin, R is camphoramic acid; in meralluride, R is succinyl-urea; in chlormerodrin, R is urea; and in mercumatilin, R is coumarin. Much of the interest in the structure-activity relationships of mercurial compounds has centered around the effects of modification of R and relatively less attention has been paid to simple organo-mercurial compounds.
A wide variety of substituted allyl compounds 1 Aided by grants from the National Heart Institute, National Institutes of Health and the Life Insurance Medical Research Fund. 2 Fellow of the Life Insurance Medical Research Fund. 3 Fellow of the Rockefeller Foundation.
are available or easily prepared as starting materials. Mercuration in methyl alcohol is relatively easy and yields of the 3-mercuri-2-methoxy propyl end products are satisfactory. Logical questions which arise include: Is the three carbon side chain of the presently used diuretics an essential or optimal element of diuretic structure, or is it merely a matter of preparative convenience?
The diuretic activity of organic mercurial compounds has recently been ascribed to inhibition of sulfhydryl enzymes concerned with the renal tublular reabsorption of sodium and chloride ions (2, 3) . Mercuric chloride and certain relatively simple organo-mercurials, including bromomercuri-methane, bromo-mercuri-benzene and parachloromercuri-benzoate, are potent and more or less specific inhibitors of sulfhydryl enzymes in vitro (4, 5) . Are these compounds also diuretics and are their diuretic activities in any way related to their activities as enzyme inhibitors?
Mercuhydring (6, 7) and Neohydring (8, 9) have been shown to disappear rapidly from the blood stream following intravenous administration and to accumulate in the renal cortex in high concentration. Both drugs are highly bound to plasma proteins, hence are sparingly filtered through the glomerular capillaries, yet both are rapidly eliminated in the urine. Accordingly, tubular secretion must play a role in their excretion. We are indebted to Dr. H. L. Friedman of Lakeside Laboratories, Inc. for directions for the preparation of chlormerodrin and meralluride and also for a supply of both the allylurea and the succinylallylurea used as starting materials. We are similarly indebted to Dr. C. M. Suter, of the Sterling-Winthrop Research Institute for advice on the preparation of mersalyl and for a supply of o-allylcarbamyl-phenoxyacetic acid. The remainder of the syntheses were taken from the literature and the appropriate references are noted in Table I .
All syntheses were performed several times with nonradioactive mercury prior to a radioactive run. Structures of end products were not proved. However, criteria of adequacy of preparation included reproducibility of product, melting point, solubility characteristics and gravimetric mercury analysis as the sulfide. Brief descriptions of these characteristics of the compounds synthesized are included in Table I .
Chemical procedures employed in the analyses of blood, urine and tissue samples are those described in a previous communication (9 taken up by cortical tissue, half the maximum concentration being attained in 15 minutes. The concentration of chlormerodrin in the kidney reached a peak about one and one-half hours after intravenous injection and then gradually declined. In contrast, the concentration of 3-acetomercuri-2-methoxy-l-hydroxy-propane increased somewhat more gradually and reached a plateau between two and three hours after injection. The concentration of mercury in the renal cortex and in representative tissues at the end of each of these two experiments are given in Table II . It is evident that the kidney concentrates each substance highly with respect to plasma, that the liver, spleen and lung concentrate them very slightly and that the remaining tissues do not concentrate them at all.
The rate of excretion of mercury, in per cent of dose administered, and the glomerular filtration rate, as measured by the creatinine clearance, are also given in Figures 1 and 2 . Excretion of mercury was rapid following both mercurial compounds and in the two hours and forty minutes following intravenous administration; 54.9 per cent of the chlormerodrin and 66.6 per cent of the 3-acetomercuri-2-methoxy-1-hydroxy-propane were eliminated in the urine. The two compounds exhibited equivalent toxicity in a dose of 2 mg. of mercury per kilo when toxicity is expressed in terms of depression of glomerular filtration rate. In both experiments, the creatinine clearance dropped about 30 per cent following the mercurial.
In Table III All of the diuretic compounds of mercury shown in Table III are more or less rapidly eliminated in the urine. From 10 to 70 per cent of the dose was excreted in the two hours and forty minutes after intravenous administration. The clearance 7 of mercury ranged from 7 to 45 cc. per minute. Since these compounds were from 99.4 to essentially 100 per cent bound by plasma proteins, they 8 Depression of filtration rate is no doubt due in part to the rapidity of intravenous injection of the diuretic, i.e., 20 seconds. 7 Because of the rapid uptake of the mercurial compounds by the renal tubules early in the course of the experiment, their combination with cysteine in the tubular cells and their secretion into the urine, clearance has a somewhat different connotation than it usually has. Uptake of mercury by the renal cortex, as measured by a Geiger tube in contact with the kidney surface, was very rapid in both experiments; half the peak concentration of each compound was attained within 1 to 2 minutes. However, the concentration of p-chloromercuri-benzoate reached a plateau early, whereas that of 3-iodomercuri-2-hydroxy-propane continued to rise throughout the experiment. Early ing of p-chloromercuri-benzoate is no doubt related to its rapid urinary excretion, the continued slow rise of 3-iodomercuri-2-hydroxy-propane to its negligible excretion, for renal concentration is no doubt directly proportional to rate of uptake and inversely proportional to rate of excretion. As is evident from Table IV, the final renal cortical concentration of each compound was similar to that of 3-acetomercuri-2-methoxy-1-hydroxy-propane (cf., Table II ). Most striking, however, is the very high concentration of 3-iodomercuri-2-hydroxy-propane attained in the spleen, the splenic value exceeding even the renal. The hepatic concentration of this compound is also relatively high.
In Table V It is evident from Tables III and V that all compounds, both diuretic and non-diuretic, are concentrated in the renal cortex. Although chlormerodrin, which is the most active of the diuretics studied, is also most highly concentrated in the kidney, the degree of concentration of the remaining compounds seems entirely unrelated to diuretic potency. Figure 5 illustrates the distribution of mercury in the kidney in four experiments in (9) . Results presented in this paper demonstrate that non-diuretic compounds of mercury are likewise concentrated in kidney tissue and that their distribution within renal cortex, medulla and papilla is both qualitatively and quantitatively similar to that of diuretic compounds. Accordingly, binding by renal tissue is not a feature which distinguishes diuretic from non-diuretic compounds of mercury.
It is generally believed that the combination of inorganic mercury, split off from the diuretic, or of the free mercury bond of the intact diuretic molecule with renal sulfhydryl enzymes renders those enzymes inactive and results in diuresis (2) . Recent evidence supports the thesis that the intact molecule rather than inorganic mercury is the active agent (11, 12) . Our results demonstrate that compounds active in vitro as inhibitors of sulfhydryl enzymes are not necessarily diuretics in vivo. Thus of the four commonly used inhibitors of sulfhydryl enzymes in vitro, three, namely bromomercuri-methane, bromomercuri-benzeneand p-chloromercuri-benzoate, have no diuretic activity in zvvo. If inhibition of sulfhydryl enzymes is a significant element of the diuretic process, then the inhibitor must have properties other than, or in addition to, those of the three compounds mentioned above.
All of the mercurial compounds which we have studied have been so highly bound to the plasma proteins that little could be filtered through the glomeruli; most of that which enters the urine must have been eliminated by tubular secretion. Of the 13 compounds studied, 6 with diuretic properties are rapidly excreted, while 6 of the 7 without diuretic properties are slowly excreted.
One might infer that active tubular secretion of a mercurial compound leads to its accumulation in a region where enzymes significant for the reabsorption of salt and water are located. Blockade of these enzymes results in diuresis. Against this view is our finding that p-chloromercuri-benzoate, which is not a diuretic, is rapidly excreted in the urine, presumably by the same mechanism responsible for the secretion of the several diuretic agents.
More or less by exclusion, we have been forced to the view that steric configuration is significant in determining whether or not a given compound of mercury will have diuretic properties. We suggest that some "critical lock and key" relationship 8 diuretic activity, for we have been unable to synthesize and test such compounds. Furthermore, certain compounds (13), most notably Novasurol, have been assigned structures which are in opposition to this thesis. In general, however, the structures of these compounds have not been well established; possibly they constitute no contradiction. Furthermore our criteria of diuresis are more restrictive than those applied by others. Compounds which others have claimed to be diuretics, might in our hands be devoid of diuretic properties. It is perhaps best to consider our thesis merely as a working hypothesis and to admit the possibility that other structures might well be consonant with diuretic activity.
SUMMARY
Twelve organic compounds of mercury and mercuric chloride have been studied with respect to diuretic properties, effects on renal function, regression of plasma concentration and tissue distribution in acute experiments on dogs. Each compound was administered intravenously in doses of 1, 2 and 4 mg. of mercury per kilo of body weight.
Six of the 13 compounds exhibited diuretic properties, seven did not. All compounds were accumulated in the kidneys and no relation between pattern of distribution or renal concentration and diuretic activity could be established. Those compounds which were slowly excreted in the urine exhibited no diuretic activity. Probably other structures are compatible with diuretic activity; however, many are not.
